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Abstract
This paper will provide a brief history and description
of the Cochlear Implant, including early research,
development, experimentation, and implementation of
the implant plus the names of many of the most
renowned developers and producers.
Second: Adam Kissiah's involvement in hearing
research subsequent to the experience of personal
hearing loss onset in the Early 1970s, deriving design
of basic specifications for simulation of the electronic
functioning of the inner ear (Cochlea) in humans.
Kissiah’s subsequent award of Patent (4,063,048,
December 13, 1977) accomplished through the
Kennedy
Space
Center’s
Technology
Commercialization Program and Patent Counsel,
James O. Harrell, Esq.
Third: How our natural hearing mechanism works,
and how the Cochlear implant works in the correction
of
hearing
loss.
Fourth: Information regarding implant availability
including manufacturers, costs, clinics, surgical
aspects, and post-operative activation (therapy)
considerations.
Fifth: Sources for additional information.

1. Introduction

It is the desire of this paper to provide you with
some information that you will find interesting, and
will perhaps answer some questions you may have
about hearing in general and the cochlear implant
specifically. I would be especially delighted if you
learn something that could make a beneficial change in
your life, or in the life of a family member or a friend.
The cochlear implant has emerged over the last
twenty five years, and especially in the last five years,
as a most welcome instrument in life enhancement for
many previously deaf and hard-of-hearing persons. It

has done so by providing a means of hearing for the
first time for many persons, and by restoring hearing
from years past for many others; yet it remains a
controversial subject for many, both in the deaf
community, and to hearing persons as well.

2. History of the Cochlear Implant

The idea for artificial or electronic correction of
hearing loss was first publicized in 1957 when the
French team of Djourno and Eyries implanted a patient
with a single electrode into the middle ear cavity near
the auditory (8th cranial) nerve, and were able to
transmit perceivable “noise” to the patient. This was
very significant in that the patient was not harmed by
the procedure and some sensation was transmitted to
him, which in turn encouraged further experimentation
and cochlear implant research.
Beginning in the nineteen sixties, and enduring to
this day, the most noted and recognized pioneer in
basic hearing stimulation research in the USA is Dr.
Wm. F. House of the House Ear Institute (HEI),
located in Sylmar (Los Angeles), CA. (Cochlear
Implants, My Perspective, Wm F. House, M.D.)
Dr. House began experimental implantation of
electrodes in humans in the early sixties. By 1969 he
had inserted single and multi-electrode implants into
several patients, and in 1971, he implanted his first
“permanent” single-wire system. Dr House implanted a
more advanced system in a patient in 1979. Also in the
1970-1982 time period, HEI, in partnership with
Minnesota Mining and Manufacturing (3M) Company,
implanted five patients through a clinical trial project.
In the 1990s Dr. House and HEI also participated in
development of the ALL-HEAR single-electrode
system. HEI has recently gained encouraging results in
experiments with brain-stem implants where the
acoustic nerve (eighth cranial) is inoperative. Also,
good results have been obtained in hybrid implants, in

which patients with good low–frequency hearing
sensitivity, but extremely poor high–frequency
response, can benefit.
Dr. House and the House Ear Institute (HEI) are the
forerunners of the current Advanced Bionics
Corporation, one of the three major providers of
cochlear implants today.
The second person or group of note is the wellknown and highly praised Dr. Graeme Clarke of
Sydney, and the University of Melbourne, Australia,
forerunners of Cochlear Americas, Ltd. They are the
second (of three) major manufacturers.
Dr. Clark and colleagues also began their research
program in the 1960s. He was highly supported by the
Australian government, and his program was on par
with Dr. William House and the USA research
programs. In 1977, he published the results of a multielectrode implant. Another report in 1979 published by
the Australian team described a multi-channel device
that would eventually lead to their most popular
implant, namely the Cochlear Americas’ “Nucleus”.
Other well-known researchers during the time period
beginning in the late seventies and early eighties
included Dr. Blair Simmons and Dr. Robert White of
Stanford University, who produced significant results
in Cochlear implant development in their Stimuliss
program and their Bioear program in association with
Biostim, Inc.
There was also Drs. Michelson,
Mersenich and Schindler of the University of San
Francisco Medical Center, Dr. Claude Henri-Chouard
of France, Dr. Donald Eddington of the University of
Utah, principle researcher in development of the
Inneraid implant, and Dr. Thomas Balkany, at the
Denver Ear Institute, and later at the University of
Miami and Jackson Memorial Hospital.
It is noted that these early implants did not (yet)
employ to the fullest extent the principles of synthesis
of the audio spectrum and application of the placespecific-audio components directly to specific
locations of the acoustic nerve, as specified in patent
4,063,048 (see below). As a result the patients sensed
primarily background noises, and did not enjoy the full
potential of the intelligence and communication factor
of the spoken word, except as an aid to lip-reading.
This new life-sense did, however, achieve the highly
desirable quality of enabling deaf persons to emerge
from the isolation of silence and enter the world of
sound,
which
significantly
improved
their
“attachment” to society.
Still other notables of this era included Dr. Blake
Wilson, Charles Finley and others at the Research
Triangle Institute in Raleigh-Durham, NC, who
pioneered in forming the Med-El Corporation, maker

of the Pulsar CI-100. Med-El, Ltd is head-quartered in
Innsbruck, Austria.
Important research was also conducted (by others)
at the University of Utah, the University of Oregon,
and still others at the University of Toronto.
Adam Kissiah of NASA-Kennedy Space Center
(KSC) in Florida was also involved in his personal
prosthesis design research during this time period.
While employed with NASA-KSC, Kissiah, because of
personal hearing problems, involved himself in a study
of the general aspects of hearing. As a result, a design
for the electronic simulation of the operation of the
human cochlea (inner ear) was devised. U.S. Patent
was applied for through the Kennedy Space Center
Technology Commercialization Program, James O.
Harrell, Patent Counsel. Patent 4,063,048 was granted
(issued) December 13, 1977, Reissue 31,031 on
September 14, 1982. This was the first U.S. (worldwide) Patent describing the basic design of the
cochlear implant. It was considered a breakthrough in
design for providing artificial stimulation of the
cochlea, providing realistic correction for hearing loss
in humans.
More than 50 subsequent patent application
referred to 4,063,048 as prior art in that field. This
technology has therefore been available, and utilized
since December, 1977. It is noteworthy and
appropriate that member of the technical community
should contribute the electronics design of the cochlear
implant, and it is equally appropriate that the medical
community should develop and produce the implant
for the public.
Below is a copy of the original (first page) Patent
(4,063,048) which provides the basic specifications for
all cochlear implants:

It is noted that the basic designs of Implants of today
are unchanged from Patent 4,063,048 (Dec 13, 1977)
except for ever evolving physical and performance
improvements through modern developments in
miniaturization, micro-circuitry, and both hardware
and software applications designs. For comparison
with modern design refer to the design of Dr. Phillip C.
Loizou, Professor in the Engineering Department of
The University of Texas at Dallas. See
www.utdallas.edu/~loizou/cimplants/tutorial/loifig4.gif

3. The National Institutes of Health’s Role
in Cochlear Ear Implant Development

In the late seventies and early eighties and beyond,
as a result of research by the leaders above, and
technology breakthroughs (the Patent described), the
National Institutes of Health (NIH) increased
significantly its output of research money to university
and other research centers. The NIH provided funding
and guidance under the direction of Dr. F. Terry
Hambrecht, director of the National Institutes for
Neurological Diseases and Stroke (NINDS), and they
also provided a central focus point for the cochlear
implant’s development and production process.
Contributions by private investors and donors also
added significant funds in promoting a high level of
research in all sectors of society in development of the
cochlear implant.
The above shows clearly that the National Institutes
of Health and many persons and institutions
contributed significantly to the development and
production of the cochlear implant.

4. The (Natural) Hearing Mechanism and
How It Works

Cochlear Implant Design – Patent 4,063,048 (12/1977)

The human hearing mechanism is a bio-engineering
master-piece. The external ear helps direct sound
waves, or acoustic energy, to the eardrum, causing it to
vibrate. These vibrations are transmitted through the
ossicular chain of bones (maleus, incus, and stapes),
through a small oval-shaped window into the inner ear
(cochlea).
Below: The Cochlear (Basilar) Membrane: From
IEEE Engineering and Medicine and Biology, Volume
6, Number 2, June, 1987 – Article Entitled “Coding of
Acoustic Signals on the Auditory Nerve”, by G. Daniel
Geisler, the University of Wisconsin-Madison.

deficiencies, disease, ototoxic drugs, loud noises, and
other causes.
There are other physical abnormalities that result in
“conductive” hearing loss in humans, such as
otosclerosis (calcification), infection, scar tissue, fluid
and wax build-up, etc. These losses are usually
treatable locally by ear-nose and throat doctors.
As stated above, Patent 4,063,048 represents the
first patented description of the basic specifications for
the functioning of the human cochlea, and a means for
correction for hearing loss from loss of “hair cells”.
Because all implants share a common basic design,
there is no clear-cut consensus that any one of the
implants is superior to the others. All cochlear implant
devices, however, display a wide range of
enhancements, including physical designs and
performance characteristics.

Figure 1: Schematic sketch of the cochlea, stretched
out from its actual spiral form, catching a midfrequency traveling wave at a particular instant.
Adapted from Zweig et al. IEEE copyright line (©

Shown below is the Biostim Inc
Implantable Hearing Stimulator I, (1980©)

1987).

The cochlea is a bony cavity, shaped like a small
snail shell, which is divided into two inner sections by
a flexible membrane called the basilar, or cochlear,
membrane. Vibrations, or sounds, entering the cochlea
create waves, like sonar waves, in the fluid-filled
cavity within the cochlea. This wave motion causes
resonating vibrations at specific locations on the
cochlear (basilar) membrane in accordance with the
stimulating frequency(s). In normal hearing, some
15,000 to 20,000+ delicate nerve endings, called hair
cells, are attached on one end to the flexible cochlear
membrane and the other to the acoustic (8th cranial)
nerve.
The cochlear membrane extends the full internal
length of the Cochlea. These mechano-electric nerves
(hair cells that fire when agitated) generate electrical
impulses in intelligent wave patterns in response to
audio stimuli (waves), which are in turn transmitted to
the hearing center of the brain by way of the auditory
nerve. These wave patterns are recognized as “sound”
which can contain “intelligence” which we label as
voice, music, and many other classifications of audio
information.
In many deaf and hard of hearing persons these
vital and delicate nerve endings that provide the link
between the vibrating cochlear membrane and the
acoustic nerve are missing. Reasons for the missing
nerves range from physical trauma, inherited

Above is a pictorial display of an implantable
hearing stimulator designed by Biostim, Inc., a
biomedical instrumentation development company in
1980. Biostim, Inc., Lloyd A. Ferreira, President and
Chief Executive Officer, was headquartered in
Princeton, NJ, and working through contractual
licensing agreement from Adam Kissiah, Jr., inventor
of the design. In 1982 Biostim, Inc. through its
subsidiary, Bioear, Inc. undertook a research program
of the same name (Bioear) under an FDA approved
experimental permit, an Investigational Device
Exemption (IDE) in association with Stanford
University, Dr. F. Blair Simmons, principal
investigator and Dr. Robert White, Chairman of the
Department of Electrical Engineering.

....---

Biostim,
(1980©s)

Inc.

Implantable

Hearing

Stimulator

5. How the Cochlear Implant Works

Sound waves are picked up by a tiny microphone
housed in a headpiece that is worn at ear level. The
microphone output is routed to a processor, which
synthesizes and rectifies the sounds into audio
“spectral bands” with the aid of a number of band-pass
filters. Envelope detectors convert the spectral bands
into digital (pulsatile) signals.
The digital impulses are shaped and controlled in
amplitude, pulse-widths and application rates, etc. and
routed to the primary windings of an electromagnetic
transmitter. In some models, the microphone and
transmitter are in the same piece, and in other models
the microphone is in a behind-the-ear piece that looks
like a standard hearing aid.
The transmitter, which is held by a magnet on the
side of the head behind the ear, sends the pulsatile
signals via magnetic induction, through the skin to the
cochlea via receiver electrodes that have been inserted
into the cochlea. These electrodes provide direct
stimulation to the brain via the auditory nerve, sending
impulses in intelligent wave patterns where they are
interpreted as sounds.
In recent years extensive (and very competitive)
experimentation has been performed by all
manufacturers in an effort to exploit all possible
methods of synthesizing and applying the audio
spectrum of electrical stimuli to the acoustic nerve, in a
continual effort to achieve the maximum possible
intelligence, fidelity and clarity of audio information.
The preponderance of current usage is the outgrowth
of the multi-channel design described in Patent
4063048 (Dec, 1977)), although many experiments by
the House Ear Institute in the single channel implant
have achieved success in specialized applications.
Many new strategies for increasing the (effective)
number of audio channels being applied to the acoustic
nerve have been developed, thereby providing greater
fidelity in a true reproduction of original audio inputs.
These capabilities have resulted in dramatically
increased so-called “open-set” comprehension scores
for words and sentences in clinical trials and in true
public environmental situations. All manufacturers
make the greatest effort to ensure “backwards
compatibility” of new applications, in order to make
certain that new developments and modifications to
implants are made available for upgrade to patients
with older models of implants. This policy enables
most cochlear implant users to be able to take
advantage of the latest in implant technology. In some
cases, older implants are replaced with new ones in
order to receive these upgrades. Such terminology used
by MED-EL as Continuous Interleaved Sampling
(CIS), Virtual Channel Interleaved Sampling (VCIS),
Compressed Analog (CA), are examples of the

somewhat descriptive terminology of the several
proprietary methods of the application of stimuli, both
software and hardware oriented. These innovative
methods have resulted in an accompanying dramatic
increase in the effective number of channels of applied
stimulus, and thus the intelligence conveyed.
6. Selection Process for Candidates for the

Cochlear Implant.

Infants and small children are placed in a special
category. More on this will be discussed in 6.1.
The early childhood and adult candidate for an implant
may obtain referral by a family physician or ear-noseand throat (ENT) physician to a known implanting
physician, clinic or implant team; or the patient may
make direct phone contact with an implant team/clinic
(information provided herein). Next, an appointment
or interview will be scheduled.
Candidates will be scheduled for an examination by
a medical doctor and an audiologist for a detailed
hearing examination. A detailed psychological profile
will also be established. Some (not all)of the basic
qualifications are: Severe to profound hearing loss in
both ears (70 db or greater); post-lingual onset of
severe to profound hearing loss in adults; limited
benefit from hearing aids; desire to improve hearing;
realistic expectations; no medical contraindications.
At this point, approval to receive an implant will
be recommended or denied. If approved the candidate
will be advised of costs, and your financial status will
be determined. You will be advised to seek approval
of insurance coverage before advancing further into
the program.
It is important that the candidate make certain to
inquire into the complete insurance coverage of all
costs, including pre-surgical physicals, hearing
examinations, psychological profiles, the surgery itself,
plus the complete processor and all its parts and
accessories. Make certain that the extensive postsurgical audiological activation, programming
(mapping) and speech therapy are included. Prior
written approval of insurance coverage before surgery
will avoid costly surprises.
Costs of the implant are thirty to sixty thousand
dollars in the US but are gradually being reduced
because of more efficient procedures and routines,
insurance company pressures, and some competition
from overseas.
If approved, surgery will be scheduled and
completed. Follow-up rehabilitation, plus extensive
audiological training and therapy will be performed.
The success rate for surgeries and electronics
operability is 99 percent-plus. Success in

understanding of the spoken word, and general
usability of the implant is dependent on many factors,
including the length of time of deafness, age,
psychological factors, effort made to learn, and so on.
Instantaneous achievement of full benefits of hearing
and understanding is not to be expected.
The post-surgical audio programming is highly
important. In many cases, maximum hearing benefit
from the implant cannot be achieved without this
formal and extensive programming (mapping), therapy
and training. It can literally make the difference
between success and failure to achieve maximum
benefits from the implant.

6.1 Early intervention

Children and babies as young as 1 year old can
receive cochlear implants. The U.S. Department of
education makes a hearing loss brochure available
entitled
“Opening
Doors:
Technology
and
Communications Options for Children with Hearing
Loss.”
The brochure is distributed by each state’s early
intervention program and is on the U.S. Department of
Education’s
website
at:
www.ed.gov/about/offices/list/osers/products/opening
doors/. The brochure provides information to help
parents make important decisions about their
children’s hearing health.
Implanting of senior citizens - Dr. John Niparko of
Johns-Hopkins University, in the Department of
Otolaryngology, Head and Neck Surgery in Baltimore
reported that in 2005, individuals over the age of 65
accounted for 24% of cochlear implant surgeries (HLA
Convention, 2006). Medicare provides insurance
coverage for patients who qualify. Patients in their
seventies, eighties, and even nineties have been
successfully implanted.

7. Some Commercial Implant Providers

As stated above, because all implants share a
common basic design, there is no clear-cut consensus
that any one of the implants is superior to the others.
Users of all three devices display a wide range of
enhancements, physical designs and performance
characteristics.
Advanced Bionics Inc. is a subsidiary of Boston
Scientific, Inc., a company that is also a major
manufacturer of heart pacemakers. Advanced Bionics
is an outgrowth of Dr. William F. House’ Hearing
Research Center, now named the House Ear Institute
(HEI). They were the makers of the older “Clarion”
model implant, and they are also known as the maker
of the “Bionic Ear” Hi-resolution (Hi-Res) system.

Their latest models include the Hi-Res 90k implant and
the Hi-Res “Auria”, with web sites at
www.cochlearimplant.com, and www.bionicear.com.
Their offices are located in Sylmar, CA and France.
The leader in the total number of Cochlear Implants
made world-wide is the Australian Cochlear Americas,
Ltd., headquartered in Sydney, Australia and maker of
the Nucleus Freedom implant, with over 80,000
persons
implanted.
Their
web-site
is
www.cochlearamericas.com.
Med-El, Ltd.’s headquarters are in Innsbruck,
Austria, with primary U.S. Offices in Raleigh-Durham,
NC. Med-El makes the Combi 40+ implant and the
New Pulsar CI-100 which includes their latest and
most improved Med-El technology. Med-El’s website
is www.medel.com.
MXM
Laboratories
–
Digisonic,
Inc.
www.mxmlab.com.
AllHear,
Inc.
Post
Office
Box
330
Aurora,
Oregon
97002
(503)
266-6730
(voice)
(503)
266-6418
(fax)
AllHear@AllHear.com
Since all of these devices have a similar range of
performances, other criteria are considered when
choosing a cochlear implant, such as usability of
external components, cosmetic factors, battery lifewhether replaceable or rechargeable, versatility of
internal and external components, customer service
from the manufacturer, the implanting physician,
audiologist and the quality of association (familiarity)
of personnel with a particular device, and other
physical concerns. Only you can decide which is best
for you.

8. Some Internet Information Sources
Deafness Research Foundation www.drf.org is a
8201 Greensboro Drive, Suite
8201 McLean, VA 22102
Phone (703) 610-9025

Gallaudet University www.gallaudet.edu is the world's
only university geared specifically to the needs of the
deaf. The site includes links to other deaf schools in
the United States.
The National Association of the Deaf (NAD)
http://www.nad.org/. The NAD advocates the civil
rights of the deaf and hard-of-hearing in a variety of
areas including education, employment, health care,
social services and telecommunications.
614 Thayer Avenue
Silver Spring, MD 20910-4500
Phone (301) 587-1791

The National Theater of the Deaf (NTD)
http://www.NTD.org/ offers information about
upcoming performances, workshops and classroom
visits.
Silent News.org http://www.silentnews.org is a
magazine Website that offers deaf news, message
boards, and classifieds.

9. Additional Sources for Information

Alexander Graham Bell Association for the Deaf and
Hard of Hearing (A.G. Bell) 3417 Volta Place, NW
Washington, DC 20007
Voice: (800) Hear-Kid or (202) 337-5221
TTY: (202) 337-5221, Fax (202) 337-8314
Email:info@agbell.org

E-mail: info@agbell.org
Internet: www.agbell.org
The American Academy of Otolaryngology-Head andNeck Surgery (AAO-HNS)
One Prince Street
Alexandria, VA 22314
Voice: (703) 836-4444
TTY: (703) 519-1585
FAX: (703) 683-5100
E-mail: webmaster@entnet.org
Internet: www.entnet.org
The Cochlear Implant Association, Inc.
5335 Wisconsin Avenue NW, Suite 440
Washington, DC 20015-2034
Voice: (202) 895-2781
TTY: (202) 895-2781
FAX: (202) 895-2782
E-mail webmaster@entnet.org
National Association of the Deaf
614 Thayer Avenue
Silver Spring, MD 20910-4500
Phone (301) 587-1791

http://www.nad.org

E-mail: nadinfo@nad.org
House Ear Institute (HEI)
2100 West Third Street, Fifth Floor
Los Angeles, CA 90057
Voice: (213) 483-4431
TTY: (213) 484-2642
FAX: (213) 483-8789
E-mail: webmaster@hei.org
Internet: www.hei.org

For additional information exchange and interaction
with other implant patients, see the Internet:

fully informed regarding his hearing and this vital
human sensory capability.

Also search Google keyword “Cochlear Implant”, or
see website www.hearagain.org
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10. Closing Statements
It is recommended that anyone who has a question
about his or her own hearing or the hearing of a loved
one or someone you know, that you or that person
should contact qualified and practicing professionals,
or hearing clinic to be tested and screened. The
importance of being properly tested cannot be stressed
enough, especially where infants and small children
are concerned. They should be tested as early in life as
possible. Elderly people should not automatically
assume that they are too old, or that they could not
qualify. Medicare pays for implants to qualified
patients and it costs very little to ask questions.
Patients in their sixties, seventies, eighties, and even
ninety years of age have been successfully provided
with cochlear implants.
Each person is obligated to himself and his family to
ask questions and obtain information needed to be
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